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Management and outcome of chronic 
atherosclerotic infrarenal aortic occlusion 
John Ligush, Jr., MD,  Enr ique Criado, MD,  Steven J. Burnham, MD,  
George Johnson,  Jr., MD,  and Blair A. Keagy, MD,  Chapel Hill, N.C. 
Purpose: To evaluate the management and outcome of chronic atherosderotic infrarenal 
aortic occlusion (IRAO), a review of 48 patients who were treated for angiographically 
documented IRAO between January 1980 and December 1994 was undertaken. Mean 
follow-up was 45 months. Mean age was 57 years (range, 33 to 88 years). Forty-seven 
patients were heavy smokers. Symptoms included claudication i  81%, rest pain in 25%, 
and tissue loss in 15%. Impotence was documented in 73% of men. Associated arterial 
disease included inferior mesenteric artery occlusion in 31 patients, renal artery stenosis or 
occlusion in 12, superior mesenteric artery stenosis in two, and celiac artery stenosis in one. 
Methods: Forty inflow procedures were performed, including 17 thoracobifemoral bypass 
(TBF) procedures, 15 aortobifemoral/iliac bypass (ABFI) procedures, and eight axillo- 
bifemoral bypass (AXBF) procedures. Eight patients were managed without surgery. The 
thoracic aorta was chosen as the inflow source in 17 patients because of previous abdominal 
aortic surgery in eight, poor status of the abdominal aorta in eight, and horseshoe kidney 
in one. 
Results: The overall operative mortality rate was 5%, and the perioperative morbidity rate 
was 18%. There was no statistical difference in perioperative mortality and morbidity rates 
among the operative groups. The five-year survival rate (life-table) for all IRAO patients 
was 67%. TBF and ABFI revascularization procedures yielded 5-year patency rates of 71% 
and 79%, respectively (p < 0.05). All eight patients who underwent AXBF died or had 
occluded grafts at 3 years after surgery. Two-year patency rates (life-table) for TBF, ABFI, 
and AXBF were 92%, 92%, and 44%, respectively. The AXBF patency rate was significantly 
inferior to those of TBF and ABFI ( p < 0.05). Changes in ankle- brachial indexes after TBF 
or ABFI were similar, but were significantly greater than changes after AXBF (p < 0.05). 
Three patients in the nonoperative group died, and two underwent major amputation. 
Acute renal failure did not occur in our study population. Follow-up creatinine l vels >2.0 
mg/d l  were documented in three operative patients and in one nonoperative patient, and 
none required ialysis. 
Conclusions: In patients who have IRAO, aorta-based inflow procedures are superior to 
AXBF both in hemodynamic outcome and in patency rates. Treatment of IRAO with TBF 
or ABFI yields similar long-term results; the descending thoracic aorta represents an 
excellent inflow alternative to the abdominal aorta. Clinieally significant renal impairment 
is rarely associated with IRAO. Nonoperative management of IRAO is associated with an 
increased mortality rate and a high rate of limb loss. (J Vase Surg 1996;24:394-405.) 
Although chronic infrarenal atherosclerotic aortic 
occlusion (IRAO) is a rare entity (occurrence of 
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0.15% in 31,216 autopsies), 1 it remains a significant 
clinical challenge. In his original description of  IRAO 
in 1923, LeRiche 2 documented claudication and 
impotence as the classic symptoms of this disorder. In 
truth, however, because of the chronic progression of 
IRAO, a spectrum of clinical presentations are en- 
countered. The lumbar and pelvic collateral circula- 
tion may develop to the point at which affected 
individuals remain asymptomatic. In contrast, reports 
of suprarenal thrombus progression leading to renal 
and mesenteric arterial occlusion abound in the lit- 
erature.37 
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It is this variation in the presentation and severity 
of associated symptoms that has led to several points 
of controversy regarding the treatment of IRAO. In 
particular, the fundamental rgument over the preva- 
lence of proximal thrombus propagation leading to 
renal and visceral artery occlusion has been a point of 
ongoing debate. As a result, controversy continues 
over the need for in-line aortic reconstruction with 
proximal thromboendarterectomy (TEA) to remove 
infrarenal thromhus 4,s,7 versus extraanatomic or re- 
mote bypass without addressing the proximal throm- 
bus. 8-1° In addition, issues uch as long-term survival 
and limb loss rates with or without operation remain 
imprecisely defined. 
In an effort to clarify some of the management 
issues and expected outcomes in patients who have 
IRAO, we herein review a 14-year experience of 48 
patients who had IRAO. More specifically, we address 
perioperative outcomes, as well as the influence of 
in-line aortic repair, extraanatomic or remote bypass, 
and nonoperative treatment on the relief of ischemic 
symptoms, limb loss rates, renal function, and long- 
term survival rates. 
METHODS 
Study population. In a search of an angiographic 
database :at the University of North Carolina Hospi- 
tals, 65 patients had an aortic occlusion identified 
from 1980 to 1994. Seventeen patients who had acute 
embolic occlusion were eliminated from analysis. 
Forty-eight patients had chronic IRAO. Retrospec- 
tive data was collected from medical records, office 
charts, and telephone interviews. All patients had 
adequate follow-up for study (range, 8 to 160 
months; mean, 45 months). A study of patient char- 
acteristics and associated risk factors was performed 
(Table I). 
Angiographic analysis. Each angiogram that was 
identified through the angiographic database was 
reviewed in detail (Table II). The presence of IRAO 
was confirmed, and associated mesenteric and renal 
artery lesions were documented. A renal artery 
diameter-reducing stenosis of_>50% was considered 
significant. Examination of the infrainguinal arterial 
runoff was performed. 
Treannent groups. A total of 40 patients under- 
went inflow operations with either thoracobifemoral 
bypass (TBF; n = 17), aortobifemoral/iliac bypass 
with proximal thromboendarterectomy (ABFI; 
n= 15), or axillobifemoral bypass (AXBF; n= 8). 
Eight patients were treated without surgery (Table 
III). Of the eight nonoperative patients, five refused 
operation and three had minimal symptoms. 
Table I. Patient characteristics in 48 cases 
of IRAO 
Mean age (yr) 59 (range, 33 to 88) 
Sex 
Male 26 (54%) 
Female 22 (46%) 
Risk factors 
Smoking 47 (98%) 
HTN 28 (58%) 
Diabetes 7 (15%) 
Hypercholesterolemia 4 (8%) 
Clinical manifestations 
Claudication 39 (81%) 
Rest pain 12 (25%) 
Tissue loss 7 (15%) 
Impotence* 19 (73%) 
Acute ischemia 0 (0%) 
One or more 48 (100%) 
Comorbid conditions 
CAD i3 (25%) 
COPD 7 (15%) 
CHF ~ (i0%) 
*Nineteen of 26 men had a history of impotence. 
HTN, Hypertension; CAD, coronary artery disease; COPD, 
chronic obstructive pulmonary disease; CHF, congestive heart 
failure. 
The thoracic aorta was chosen as the source of 
inflow in 17 patients because of previous abdominal 
aortic surgery in eight patients, the status of the 
abdominal aorta in eight patients, and the presence of 
a horseshoe kidney in one patient. Axillary artery 
inflow was chosen because of the patient's choice in 
two cases and because of significant comorbid medical 
conditions that, in the opinion of the operating 
surgeon, precluded a transabdominal or thoracic 
approach in six patients (three patients who had 
congestive heart failure, two who had chronic ob- 
structive pulmonary disease, and one who had a 
combination of both). 
Outcome analysis. Analysis ofperioperative mor- 
bidity and mortality rates (Table IV), postoperative 
hemodynamic improvement (ankle-brachial in- 
dexes), amputation rates, and long-term renal func- 
tion was performed for each treatment group 
(Table V). 
Statistical analysis. Life-table analysis was ap- 
plied to determine long-term survival and graft pa- 
tency rates. %2 analysis was used to determine differ- 
ences in morbidity and mortality rates, 2-year and 
S-year graft patency rates, amputation rates, and 
long-term renal function among treatment groups. A 
paired t test was used to determine differences in 
hemodynamic outcome and changes in renal function 
within the treatment groups. An unpaired t test was 
used to compare postoperative hemodynamics be- 
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Table I I ,  A. Angiographic findings: aorta, mesenteric artery, renal artery 
Aorta # Celiac SMA IMA RA 
No.* 48 44 44 44 90 
Patent 0 43 42 3 78 
Stenotic (>50%) 0 1 2 0 11 
Occluded 48 0 0 41 1 
% Occluded/stenotic 100% 2% 5% 93% 13% 
*Number of angiograms with adequate visualization ofspecific artery in question available for angiographic interpretation. 
#All aortic occlusions occurred in infrarenal position. No suprarenal extension of proximal aortic thrombus was noted. 
SMA, Superior mesenteric artery; IMA, inferior mesenteric artery; RA, renal artery. 
Table I I ,  B. Angiographic findings: infrainguinal artery 
CFA DFA SFA POP ATA PTA PA 
No.* 82 82 81 74 72 72 66 
Patent 70 80 49 71 67 61 54 
Occluded 12 2 32 3 5 9 8 
% Patent 85% 98% 60% 96% 93% 85% 82% 
*Number of angiograms with adequate visualization ofspecific artery in question available for angiographic interpretation. 
CFA, Common femoral artery; DFA, deep femoral artery; SPA, superficial femoral artery; POP, popliteal artery; A77A, anterior tibial artery; 
PTA, posterior tibia] artery; PA, peroneal rtery. 
Table I I I .  Treatment groups 
Treatment group Number 
Total 48 
Operative 40 
TBF 17 
ABFI 15 
AXBF 8 
Nonoperative 8 
Table IV. Morbidity and mortality data 
n % 
Mortality 2 5% 
Ischemic bowel 1 
MSOF 1 
Morbidity 7 18% 
MI 3 
Ischemic bowel 1 
Pneumonia 1 
Pancreatifis 1 
Distal embolus 
MSOF, Multiple system organ failure; MI, myocardial infarction. 
tween operative groups and with nonoperative hemo- 
dynamics. A p < 0.05 was considered statistically 
significant. 
RESULTS 
Pat ient  characteristics, The patient characteris- 
tics are summarized in Table I and are not unlike those 
reported elsewhere. 4-7 The patients' mean age at the 
time of  their diagnosis was 57 years. Men oumum-  
bered women 26 to 22. Forty-seven of  the 48 patients 
were heavy smokers (average, 45 pack-years). Other 
associated risk factors present included hypertension 
in 58%, diabetes mellitus in 15%, and hypcrcholestcr- 
olemia in 8%. 
Claudication was the most common symptom 
mentioned at presentation (81%), followed by rest 
pain (25%) and tissue loss (15%). Acute ischemia did 
not occur in our patient population. A history of  
impotence was documented in 19 of  26 men (73%). 
Indications for operation did not vary significantly 
between treatment groups. 
Ang iograph ic  analysis. The results o f  the angio- 
graphic findings are summarized in Table II. In all 
cases, aortic occlusion occurred just below the level o f  
the renal arteries. In no case was evidence ofsuprare- 
nal propagation of  aortic thrombus detected. 
Adequate angiographic visualization of  the me- 
sentcric arteries was available in 44 patients. Inferior 
mesentcric artery occlusion was observed in 41 pa- 
tients (93%). Superior mescnteric and celiac artery 
lesions were rare, found in 5% and 2%, respectively. 
Renal artery stenoses (_>50% diameter reduction) 
were documented in 11 of  the 90 renal arteries that 
were visualized; three unilateral and four bilateral. 
One renal artery occlusion was detected. In no case 
did thc infrarenal thrombus affect the renal arteries at 
the time of  initial aortographic evaluation. 
Analysis o f  the runoff  anatomy revealed ahigh rate 
o f  patent infrainguinal vessels: 85% patency rate in 
common femoral arteries, 98% rate in deep femoral 
arteries, and 87% rate in popliteal artery infra- 
geniculate/trifurcation vessels. Only the superficial 
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femoral artery demonstrated a lower level ofpatency, 
at 60%. 
Outcome of operative and nonoperative treat- 
ment groups. The operative mortality rate was simi- 
lar to other reported series. 3,4,7 Two perioperative 
deaths (<30 days after surgery) occurred in the 40 
patients who underwent operation, for a 5% operative 
mortality rate. One death resulted from bowel infarc- 
tion and another from multiple organ system failure. 
Autopsy revealed no evidence of proximal aortic 
thrombus propagation that involved the visceral or 
renal arteries in either patient. Associated periopera- 
rive complications were myocardial infarction in three 
patients, bowel ischemia in one, pneumonia in one, 
pancreatitis inone, and a distal embolus in one. There 
was no statistical difference in mortality and morbid- 
ity rates between the TBF, ABFI, or AXBF operative 
groups (Table W). 
The overall 5-year survival rate for all patients who 
had IRAO was 67% (Fig. 1). Our data suggest that the 
survival rate may be improved by giving operative 
therapy for IRAO (Fig. 2), although statistical signifi- 
cance was not achieved (p = NS). 
Follow-up regarding the late causes of death was 
incomplete. Of the 17 late deaths that occurred, 
seven were "inpatient" fatalities. An autopsy was 
performed on only three patients. From the autopsy 
reports, however, no mention of aortic thrombus 
progression that involved either the renal or visceral 
arteries was made. In the remaining four patients, a
review of death certificates failed to find mention of 
acute renal failure as the cause of death in any 
patient. No mention of bowel ischemia was made on 
any of the death certificates. Ten late deaths were 
detected only by telephone interviews with family 
members. The cause of death cannot be definitively 
stated because death certificates were not available 
for review. 
TBF and ABFI revascularization procedures 
yielded 5-year primary patency rates of 71% and 79 %, 
respectively (Fig. 3). All eight patients who under- 
went AXBF procedures died or had occluded grafts at 
3 years; three patients were alive with occluded grafts, 
three died with occluded grafts, and two died with 
patent grafts. 
The 2-year patency rates ofTBF, ABFI, and AXBF 
were 92%, 92%, and 44%, respectively (Fig. 4). AXBF 
proved to be an inferior method in terms of long-term 
patency rates when compared with aorta-based inflow 
operations for the treatment of IRAO (p < 0.05). 
Two-year and 5-year primary patency rates for TBF 
and ABFI were not significantly different (p > 0.05). 
As detailed in Table V, A, hemodynamic improve- 
ment after TBF and ABFI, as determined by changes 
in anlde-brachial indexes (ABI) after operation, were 
similar (p = NS), but were significantly greater than 
those achieved with AXBF (p < 0.05). The mean 
change in ABI was 0.54 + 0.17 after aortic inflow 
procedures and 0.38 + 0.10 after axillary inflow pro- 
cedures. Postoperative ABIs were significantly greater 
for both aortic and axillary inflow procedures when 
compared with nonoperative ABI (p < 0.05). 
A trend toward improved limb salvage rates was 
detected inthe operative group (Table V, B). Six of the 
40 patients (15%) in the operative group underwent 
amputation during follow-up. This rate was lower 
than that of the nonoperative patients (two of eight; 
25%) who required amputation, though statistical 
significance was not achieved (p = NS). 
No cases of acute renal failure were detected in 
our series. In none of the operative or nonoperative 
patients did renal failure that required ialysis occur 
during follow-up (Table V, C). A total of four 
patients demonstrated an increase in serum creati- 
nine level _>2.0 mg/dl  during follow-up. Two pa- 
tients who underwent TBF demonstrated anincrease 
in serum creatinine level from 1.9 mg/dl  to 3.1 
mg/dl  and 1.0 mg/dl  to 2.0 mg/d l  over a period 
of 2 and 3 years, respectively. One patient who 
underwent ABFI had an increase in serum creatinine 
level from 1.5 mg/d l  to 2.0 mg/d l  over a period of 
3 years. A single nonoperative patient demonstrated 
an increase in serum creatininc level, from 1.7 mg/d l  
to 3.9 mg/dl  over a 6-year period. The two patients 
who underwent TBF had IRAO with documented 
bilateral renal artery stenoses, the single ABFI pa- 
tient had IRAO with bilateral renal artery stenoses, 
and the nonoperative patient had IRAO with an 
associated left renal artery occlusion and right renal 
artery stenosis. 
DISCUSSION 
Chronic IRAO has a broad spectrum of ischemic 
manifestations and poses a particular management 
challenge. As demonstrated byour data and those of 
other investigators, 4-7IRAO tends to occur in rela- 
tively young patients who have a history of tobacco 
abuse. In our patient cohort, the mean age at the time 
of diagnosis was 57 years, and the patients averaged 45 
pack-years of cigarette use. The male to female 
distribution was roughly equal in our study group (26 
men, 22 women). Compared with older published 
data, 4's the increased incidence of IRAO among 
women may be related to a higher prevalence of 
tobacco abuse in the female population. Other risk 
factors for accelerated atherosclerosis included hyper- 
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Fig. 1. Cumulative survival rates of 48 patients with IRAO. Five-year survival rate is 67% by 
life-table analysis (standard error, +10.7% at 5 years). 
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Fig. 2. Cumulative survival rates of operative and nonoperative populations with IRAO. A 
trend toward improved long-term survival is observed; however, excessive standard error in the 
nonoperative group (+33% at 5 years) makes tatistically significant conclusions invalid). 
tension in 58%, diabetes in 15%, and hypercholester- 
olemia in 8%. 
In keeping with other published series of IRAO,~-7 
the most commonly associated symptom is claudica- 
tion. Rest pain and tissue loss, however, were not rare 
findings in our series. None of the patients had acute 
ischemia, which supports the chronic nature of the 
IRAO lesion and the long-term development of 
lumbar and pelvic collateral vessels. As described by 
LeRiche, 2our male population had a 73% incidence of 
impotence. 
Long-term survival rates are adversely affected by 
the presence of IRAO. In the Starrett and Stoney 
series, 4the survival rate of patients who underwent an 
operation for IRAO was approximately 65% at 5 years 
and 40% at 10 years. Our data did not differ signifi- 
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cantly, with a 5-year survival rate of 67% in all patients 
who had IRAO. As in the Starrett and Stoney series, 
our data suggest an improved survival rate in patients 
who are treated with surgery. One possible, albeit 
speculative, reason for this benefit of surgery is that 
the patients in the operative group may receive better 
follow-up and more appropriate management of their 
comorbid medical conditions. Because the number of 
nonoperative patients in our series was small, how- 
ever, a statistically significant increased-survival ben- 
efit could not be demonstrated with operation. 
The operative mortality rate was 5% in our study 
population, which does not differ significantly from 
data published elsewhere. 4's'7 Of  the two periopera- 
rive deaths, one resulted from bowel ischemia nd the 
other from multiple organ system failure. Autopsy 
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Table V, A. Analysis of hemodynamic outcome in patients with IRAO 
Ankle-brachial index (mean + SD) 
Before surgery* After surgery? ABI change~ 
TBF (17) 0.30 -+ 0.17 0.86 + 0.13 0.56 + 0.15 
ABFI (15) 0.32 -+ 0.15 0.88 + 0.15 0.53 + 0.18 
AXBF (8) 0.22 -+ 0.12 0.60 + 0.12 0.38 + 0.10 
No operation (8) 0.39 _+ 0.16 N/A  N/A  
*No significant difference between preoperative ABI in TBF, ABFI, no operation (p > 0.05; unpaired t test). Preoperative ABI for AXBF 
significantly less than TBF, ABFI (p < 0.05; unpaired t test). 
1-Postoperative ABI was significantly increased in TBF, ABFI, AXBF when compared with preoperative ABI (p < 0.05, paired t test). ABI 
after TBF, ABFI, or AXBF significantly greater than nonoperative group ABI (p < 0.05, unpaired t test). 
;~Comparison ofTBF and ABFI reveal no statistically significant differences in either postoperative ABI or ABI change (p > 0.05, unpaired 
t test). Significantly greater ABI change occurred after TBF or ABFI when compared with AXBF (p < 0.05, unpaired t test). 
Table V, B. Analysis of limb loss in patients with IRAO 
Patients Amputations Amputation rate* 
Operative group 40 6 15% 
TBF 17 3 17% 
ABFI 15 2 13% 
AXBF 8 1 12.5% 
Nonoperative group 8 2 25% 
*Amputation rate was not significantly less in operative versus nonoperative group (p = NS, g2). 
Table V, C. Analysis of long-term renal function in patients with IRAO 
Before surgery (2_2.0 mg/dl) Follow-up* (>2.0 mg/dl) Dialysis 
Operative group (n = 40) 0 3 0 
TBF (17) 0 2 0 
ABFI (15) 0 1 0 
AXBF (8) 0 0 0 
Nonoperative group (n = 8) 0 1 0 
*No significant changes in renal function were detected within operative or nonoperative groups (p > 0.05; paired t test). No differences 
in long-term renal function were detected among treatment groups (p > 0.05; Z2). 
revealed no evidence of proximal aortic thrombus 
propagation that involved the visceral or renal arteries 
in either patient. Perioperative comorbid conditions 
occurred at a rate of  18%; these complications in- 
cluded three cases of myocardial infarction, one case 
of transient bowel ischemia, one case of pneumonia, 
one case ofpancreatitis, and one distal embolus. 
We detected no evidence of suprarenal propaga- 
tion of the aortic thrombus in any of  our 48 patients 
at the initial aortographic examination. All angio- 
grams revealed occlusion at the juxtarenal aorta. We 
detected no juxta-inferior mesenteric artery occlu- 
sions in our series. This can, perhaps, be explained by 
the high rate of inferior mesenteric artery occlusions 
present in our study population. 
Preservation of the distal, infrainguinal arterial 
run-off in the majority of IRAOs was an interesting 
finding. This observation would suggest that IRAO is 
a localized phenomenon that spares the distal vascu- 
lature. Two possible mechanisms to explain this 
finding are that: (1) IRAO occurs in a subset of 
patients who are predisposed having to accelerated 
aortic atherosclerosis; and/or  (2) occlusion of the 
proximal aortic inflow has a protective ffect on the 
distal arterial tree, that is, decreased influence of 
hypertension, tobacco, or both as predisposing fac- 
tors for the formation of distal atherosclerotic o clu- 
sive disease. 
The proposed pathogcnesis of lRAO is that ofiliac 
and distal aortic atherosclerotic disease progression 
with subsequent infrarenal aortic thrombosis. This 
thrombus organizes over time and typically ascends to 
the level of the renal arteries, where outflow to the 
low-resistance renovascular bed maintains the pa- 
teucy of the suprarenal orta. 
In our series, renal artery stenosis was detected in 
11 patients and occlusion was detected in one patient 
at the initial aortographic evaluation. Both the 
stenoses and the occlusion were related to atheroscle- 
rotic disease in all cases. In no patient was evidence of 
proximal aortic thrombus extension into the renal 
arteries detected. 
Many reports have been published, however, of 
thrombus propagation to the juxta/suprarenal posi- 
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tion that results in renal dysfunction and mesenteric 
compromise. >6 When this situation occurs, the usual 
clinical scenario isthat of acute renal failure or visceral 
ischemia, followed by death. As a result, a standard- 
ized approach of proximal aortic TEA and inqine 
revascularization has been advocated by several inves- 
tigators. <5 In this regard, the work of Starrett and 
Stoney 4 is of particular importance. In 1974 they 
reviewed a series of 55 patients with IRAO who 
received operative or nonoperative management. Of
the 13 patients who were observed without surgery, 
six had documented occlusion of one or both renal 
arteries at autopsy, five of which appeared to be 
directly re][ated to proximal thrombus extension. All 
six patients died with partial or complete renal failure. 
Similarly, in 1983 Deriu and Ballota 6 documented 
progression of the proximal aortic thrombus with 
angiograplhic examination and pathologic analysis in 
the presence of IRAO. 
In contrast, several reports of extraanatomic by- 
pass for the treatment ofIRAO have been published. 
Nunn and Kamal 8 were the first to report TBF bypass 
for IRAO in 1972, and Franz et al.9 performed an 
ascending aorta-to-femoral artery bypass procedure 
in a single patient with IRAO in 1974. These proce- 
dures have been criticized because they did not 
address t2he infrarenal aortic thrombus and did 
not eliminate the risk of proximal thrombus propa- 
gation .4-7 
It was not until McCullough et al.10 reported a
series of I 3 patients who had IRAO and were treated 
either medically or with an extraanatomic bypass 
procedure that the controversy of in-line repair was 
rekindled. None of the patients in their series dem- 
onstrated progression of proximal aortic thrombus, 
and the authors questioned the dogma of using TEA 
and in-line aortic repair. 
In the only prospective study that examined the 
progression of proximal aortic thrombus, Reilly et 
al. n studied a series of 52 patients who underwent 
surgical interruption of the inftarenal aorta and an 
extraanatomic bypass procedure during the course of 
aortic graft infection. Forty-eight patients were avail- 
able for long-term follow-up. Forty-one patients 
demonstrated no change in either blood pressure or 
renal function. Of the seven patients who had wors- 
ening hypertension r a documented rising creatinine 
level, three underwent aortography. One patient had 
a failed superior mesenteric artery-renal rtery bypass 
graft, and another had a renal artery thrombosis 
immediately after surgery. One patient had normal 
renal artery anatomy demonstrated on an angio- 
graphic scan despite a rising creatinine level. The 
remaining four patients did not undergo angio- 
graphic evaluation. Out of a total of 21 patients who 
underwent follow-up angiographic s ans, none dem- 
onstrated progression of proximal aortic thrombus. 
This compelling evidence suggested that proximal 
thrombus progression does not occur when infrarenal 
aortic interruption is accompanied byremote bypass. 
The authors cautioned, however, that his model may 
not adequately compare with the natural history of 
IRAO in that varying lengths of infrarenal aortic 
stump remain after surgical interruption with remote 
bypass, which may not allow for the formation of 
infrarenal thrombus that is invariably present in the 
long segment of occluded aorta encountered in
IRAO. 
Although we did not obtain follow-up aortic 
imaging (aortography, magnetic resonance imaging, 
magnetic resonance angiography, computed tomo- 
graphic angiography) to rule out ascent of proximal 
aortic thrombus, our long-term follow-up data, 
coupled with our angiographic findings at the time of 
initial aortography, would lend support o the find- 
ings ofMcCullough et al.10 and Reilly et al.n that his 
phenomenon is,indeed, arare event. 
In our study population, 15 patients underwent 
direct in-line aortic reconstruction with TEA or 
ABFI. Twenty-five patients underwent remote bypass 
without TEA (17 with TBF, eight with AXBF), and 
eight patients were treated without surgery. No cases 
of acute renal failure occurred during follow-up, 
which suggests that acute occlusion of the renal 
arteries did not occur. Assessment oflong-term renal 
function by means of serum creatinine measurement 
revealed that only three of 40 operative patients and 
one of eight nonoperative patients had a follow-up 
creatinine l vel >2.0 mg/dl. Two patients who un- 
derwent TBF demonstrated a rise in serum creatinine 
level from 1.9 to 3.1 mg/dl and 1.0 to 2.0 mg/dl over 
a period of 2 and 3 years, respectively. One patient 
who underwent ABFI had an increase in serum 
creatinine l vel from 1.5 to 2.0 mg/dl over a period of 
3 years. The single nonoperative patient demon- 
strated an increase in serum creatinine l vel from 1.7 
to 3.9 mg/dl over a 6-year period. None of the 
patients in our study population required ialysis. 
It is interesting to note that within the group of 
four patients who demonstrated anincrease in their 
serum creatinine l vel, the two patients who under- 
went TBF procedures had IRAO with documented 
bilateral renal artery stenoses, the patient who under- 
went an ABFI procedure had IRAO with bilateral 
renal artery stenosis, and the nonoperative patient had 
IRAO with an associated left renal artery occlusion 
and right renal artery stenosis. 
Although we cannot definitively state that the 
increased creatinine l vels were attributable to pro- 
gression of renal artery stenosis, as opposed to pro- 
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gression of renal parenchymal disease, embolization, 
or diabetic nephropathy (in selected cases), it is our 
contention that the most important determinant of 
long-term renal function in patients who have IRAO 
is the status of the renal arteries and not the propa- 
gation of proximal aortic thrombus in and of itself. 
This position is supported by several reports on 
the natural history of renal artery stenosis, 12'13 as well 
as multiple reports of simultaneous aortic and renal 
artery reconstruction) 4~16 Even Starrett and Stoney 4 
addressed concomitant renal artery stenoses in 13% of 
the operative patients who had IRAO in their 1974 
report, almost certainly influencing proximal aortic 
thrombus propagation and enhancing the preserva- 
tion of renal function in the operative arm of their 
IRAO series. In addition, given the significant num- 
ber of remote bypass procedures that are performed in
our study population without addressing proximal 
aortic thrombus (17 TBF, eight AXBF), it would 
appear that in-line aortic reconstruction with TEA or 
ABFI offers no significant advantage with regards to 
renal function, if renal artery anatomy isnot compro- 
mised. 
Although clinically significant deterioration in 
renal function was not noted in our cohort of patients 
(i.e., no need for dialysis), it can be assumed that it will 
occur at a significant rate over time if renal artery 
stenosis is present at the outset. 12'13 In this subset of 
patients itwould be most appropriate for concomitant 
aortic and renal artery repair to be undertaken. We 
agree with Bowes et al} 7 and others, 14-16 that direct 
transabdominal repair of the renal artery stenosis and 
in-line reconstruction is indicated in this setting for 
the preservation ofrenal function and the prevention 
of the potentially life-threatening ascent of the infra- 
renal aortic thrombus. 
We agree with Reilly et al.n that the presence of 
IRAO in combination with renal artery stenosis is 
particularly ominous. As renal artery stenosis 
progresses in the presence of IRAO, the low-resis- 
tance outflow to the renal parenchyma is compro- 
mised. This may result in a low-flow state at the aortic 
stump, which could potentially allow for the ascent of 
proximal aortic thrombus, as observed in other re- 
ports.47 
We must point out that although we observed no 
incidence of acute renal failure in our study popula- 
tion, as would be the case with renal artery occlusion 
in association with ascent of the aortic thrombus, we 
cannot definitively state that this scenario did not 
occur because the cause of death was poorly docu- 
mented in at least 10 of our patients. 
Although most published series on IRAO have 
focused almost entirely on the preservation of renal 
function and on proximal aortic thrombus propaga- 
tion, we examined several other factors that are 
important in the management and outcome of pa- 
tients who have IRAO. 
In particular, graft patency rates were superior 
when an aortic inflow source was used. TBF and ABFI 
procedures achieved 5-year graft patency rates that 
were far superior to those achieved by AXBF proce- 
dures. Indeed, the 5-year patency rates for AXBF 
could not be examined by life-table analysis because 
eight AXBF patients died or had occluded grafts at 3 
years. This inability to analyze the patency rate illus- 
trates the influence that patient selection has on graft 
patency rates. Five of the eight patients who under- 
went AXBF procedures were dead at 3 years; three had 
occluded grafts. The remaining three patients are alive 
but have occluded grafts. Six of the eight patients who 
underwent AXBF had severe associated medical com- 
plications that, in the opinion of the operating sur- 
geon, precluded a transabdominal or transthoracic 
inflow procedure. All five deaths occurred in this 
subset of patients. AXBF was performed because of 
patient choice in the remaining two patients; both are 
alive with occluded grafts. 
Hemodynamically, aortic inflow procedures were 
superior to AXBF procedures in achieving signifi- 
cantly greater ABIs after surgery. A significantly 
greater average increase in ABI, 0.54 + 0.17, was 
achieved with aorta-based procedures, compared 
with an increase of 0.38 + 0.11 with procedures based 
on axillary artery inflow (p < 0.05). It is interesting to 
note, however, that all forms of operative therapy 
resulted in significantly greater ABIs than those mea- 
sured in nonoperative patients, which suggests that 
operative therapy offers a greater chance of ischemic 
symptom relief. 
Further analysis of the poor results achieved with 
axillary inflow raises three specific points. First, AXBF 
grafts have inferior patency rates when compared with 
ABFI or TBF bypass grafts in most series) 8-2° 
Whether these inferior patency rates are a result of the 
length of the bypass graft, the inability of axillosub- 
clavian inflow to support he entire leg circulation, or 
the low velocity profile that is measured in AXBF 
grafts are points of ongoing debate. Second, it is well 
established that AXBF grafts yield inferior hemody- 
namic results when compared with aortic inflow 
procedures. In this regard our findings were similar to 
those of Schneider et al., 2° who reported hemody- 
namically inferior esults with AXBF even in the face 
of grade 1 run-off. 21 Finally, as mentioned above, 
AXBF is typically reserved for patients who have 
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significant comorbid conditions that preclude trans- 
abdominal or transthoracic nflow procedures. 
An additional point of concern regarding AXBF 
patency rates would be how the rate of superior 
femoral artery (SFA) occlusion influenced the re- 
sults. Further review of our angiographic data re- 
vealed that three of eight patients (37.5%) who 
underwent AXBF had bilateral SFA occlusion, com- 
pared with 5 of 15 patients (33%) who underwent 
ABFI and six of 17 patients (35%) who underwent 
TBF having bilateral SFA occlusion. There was no 
significant difference in the rate of SFA occlusion 
between the operative groups, which suggests that 
this parameter had little to do with the poor patency 
rates observed in the AXBF group. In addition, 
evidence suggests that as long as the DFA is patent 
to at least 3.5 mm in diameter, SFA occlusion has 
no influence on the long-term patency rates of AXBF 
grafts. 22 Indeed, this was the case for each of our 
patients who underwent AXBF; each DFA was 
patent to a minimum of 3.8 mm. 
The nearly identical patency rates that were at- 
tained with the ABFI and TBF procedures are in 
keeping with those from our previously published 
experience. 22The descending thoracic aorta is rarely 
diseased, .and it represents an excellent inflow alter- 
native to the abdominal aorta, particularly in the face 
of a hostile abdomen, previous aortic surgery, or poor 
status of the abdominal aorta. In our series the 
descending thoracic aorta was chosen as an  inflow 
source because of previous abdominal aortic surgery 
in eight patients, the poor status of the abdominal 
aorta in eight patients, and the presence of a horse- 
shoe kidney in one patient. 
Analysis of our data, combined with that of other 
investigators, 12-16 would suggest hat in the face of 
significant renal artery stenosis TBF would be an 
inferior operative choice for the preservation of  renal 
function because the stenosis would be likely to 
progress, resulting in the potential for proximal aortic 
thrombus progression. As mentioned above, worsen- 
ing renal function was detected uring follow-up in 
two patients who underwent TBF procedures for 
IRAO in the presence of bilateral renal artery 
stenoses. 
Although renal status did not appear to be affected 
by operative or nonoperative therapy, limb salvage 
rates may be. Although our observations did not 
achieve statistical significance, it would appear that 
amputation rates are adversely affected by nonopera- 
five therapy. A 25% amputation rate was observed in 
our group of eight patients treated without surgery, 
compared with a rate of 15% in the operative group 
(p=NS) .  As a long-term indicator of outcome, 
operative therapy may be indicated for limb salvage. 
Overall, our data indicate that patients who can 
tolerate an aorta-based inflow procedure should be 
offered this procedure because superior relief of 
symptoms, prolonged graft patency rates, and in- 
creased limb salvage rates may result. In addition, the 
long-term survival rate may be increased in patients 
who undergo operation for IRAO. 
The descending thoracic aorta represents an ex- 
cellent inflow alternative to the abdominal aorta. The 
TBF grafting procedure is identical to the more 
traditional ABFI grafting procedure in hemodynamic 
improvement and in graft patency rates. 
Renal function did not appear to be adversely 
affected by remote or extraanatomic bypass, and 
propagation of proximal aortic thrombus appears to 
be a clinically rare event. More importantly, long-term 
renal function appears to be influenced by the status of 
the renal arteries. In the presence of IRAO, direct 
aortic reconstruction a d renal artery repair should be 
considered when significant renal artery stenosis is 
present to prevent the potential for ascent of the 
infrarenal aortic thrombus with its devastating con- 
sequences. 
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DISCUSSION 
Dr. Robert  B. Smith, I I I  (Atlanta, Ga.). The authors 
have reported a sizable xperience with the uncommon and 
sometimes technically difficult problem of chronic IRAO. 
Their results seem to favor an aortic inflow source at 
operation, but it must be emphasized that the study groups 
were not really comparable in this retrospective r view. The 
procedures were not randomized, and the sickest patients 
were assigned to the AXBF bypass group. 
The review questions the dogma that uncorrected total 
aortic occlusion threatens the patency of the renal arteries 
by the proximal propagation of thrombus. The authors 
concluded that suprarenal thrombosis seldom occurs. We 
agree with them on the basis of our anecdotal experience, 
but the data from their study are inconclusive in this regard. 
It is true that none of the patients became anuric or required 
dialysis during follow-up, but several did exhibit worsening 
of renal fimction over time. How can you be sure without 
angiographic invcstigation that ascending renal artery 
thrombosis was not responsible for the worsening azotemia 
in those patients? 
Furthermore, the analysis presented suggests that the 
correction of coexistent atherosclerotic renal artery stenosis 
might be more important than the prevention of progres- 
sive aortic thrombosis in the late preservation of renal 
function. That conclusion also is somewhat speculative, 
because adjunctive renal artery reconstructions were not 
undertaken i these patients. Do the authors recommend 
that the operation be modified to include renal revascular- 
ization in addition to aortic repair in selected patients who 
have significant stenosis? 
Finally, I am intrigued by a different cohort of their 
patients, the individuals who develop abundant collateral 
vessels or are so sedentary in their lifestyle that they are 
essentially asymptomatic despite total IRAO. Dr. Ligush 
and his coauthors observed that symptomatic patients who 
undergo surgical treatment achieve better survival rates 
than those who are managed without surgery. Does that 
same interpretation also apply to patients who we have all 
seen who have minimal to no complaints despite absent 
femoral pulses? Should these individuals be investigated and 
surgically treated as well to improve their long-term survival 
rates? 
Dr. John Hgush, Jr. Regarding the AXBF bypass 
procedure, there is no question that the group of patients in 
our series that underwent AXBF bypass procedures were a 
sicker cohort of patients. Six of the eight patients were 
considered to have significant comorbid conditions that 
precluded an abdominal or thoracic approach, and two of 
the patients actually chose to have axillary inflow proce- 
dures. So commenting on the long-term survival rates of 
those patients i  probably not appropriate. 1 would venture 
to say that we almost always offer those patients who can 
tolerate abdominal or thoracic approaches the abdominal or 
thoracic procedures and not an axillary inflow procedure. 
Also axillary inflow procedures are associated with a lower 
hemodynamic response in our series, even looking at 
patients with class 1 run-off; their postoperative ABIs did 
not approach those of aortic inflow procedures, and that is 
in keeping with other reported series. 
As far as challenging the dogma of proximal aortic 
thrombus progression, there is no question that Dr. 
Stoney's group at the University of California, San Fran- 
cisco, has written the classic papers on this topic, and they 
have encouraged us to perform direct in-line repair. We did 
not see proximal thrombus progression at the time of the 
initial aortographic s an. We did not perform postoperative 
aortographic s ans, however. Much of our data is inferen- 
tial. However, if you couple the inferential data from our 
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series with those presented (also from Dr. Stoney's group) 
by Linda Riley looking at aortic stump closure and AXBF 
bypass, you find that seven of the 48 patients who were 
observed prospectively developed worsening renal func- 
tion. Only three of those patients were studied with 
angiographic s ans. None of them demonstrated proximal 
thrombus progression. A total of 21 patients in that series 
had angiograms after surgery, and none of them had 
proximal thrombus progression. So we infer that it is a rare 
event. We think that it occurs more frequently in the face of 
renal artery stenosis where the low resistance renovascular 
bed is compromised. 
As far as the asymptomatic group, I cannot really 
comment on that as far as the long-term outcome data. 
Whether patients with bilateral ilac stenoses hould be 
randomized to operative versus nonoperative treatment is
an ongoing question. There are not many randomized trims 
in vascular surgery as a whole, and in this patient population 
there are basically none. 
Dr. Spence Taylor (Greenville, S.C. ). Dr. Smith's third 
question intrigues me. Should these patients be treated any 
differently than anybody else who has aortic occlusive 
disease? In other words, if you operate on people with 
lifestyle-limiting claudication, tissue loss, and limb salvage 
situations as indications for iliac occlusive disease, should 
the magical situation where your aorta is occluded preempt 
that and a more aggressive approach be pursued? 
Dr, Ligush. I think our data would suggest that a more 
aggressive approach be undertaken. I temper that a little bit 
by saying that the longest survivor in our series, at 160 
months, is a patient who had no operation. So I am not sure 
that I can answer the question directly. We take the same 
approach. I f  the patients have symptoms and if they have 
lifestyle changes or ischemic hanges distally, we offer them 
repair. 
Dr. Smith did ask one other question regarding renal 
artery steuosis, and I think from our data and the data 
presented here by Dr. Cambria that we would take a bit of 
a more aggressive approach to renal artery disease in this 
setting. We certainly would not offer patients aTBF bypass 
procedure now in the face of bilateral renal artery stenosis. 
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